Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Celera Genomics and Gemini Research establish research collaboration

Sep. 7, 1999

SkyePharma acquires nanoparticle technology

Sep. 7, 1999

PDL granted new European patent covering humanized monoclonal antibodies

Sep. 7, 1999

3-Dimensional awarded two research grants from NIH

Sep. 6, 1999

Ligand and Parke-Davis establish research collaboration

Sep. 6, 1999

Licensing opportunity from NIH: drug delivery system for water-insoluble drugs

Sep. 6, 1999

Orally bioavailable, ETB receptor-selective antagonists designed by Abbott

Sep. 3, 1999

Millennium extends CNS collaboration with Wyeth-Ayerst

Sep. 2, 1999

Repligen receives SBIR grants to support discovery of novel active compounds

Aug. 27, 1999

Pharmacopeia to provide lead discovery services to Roche Bioscience

Aug. 27, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...